Hi Maldowl. The market only wakes up to CDY events such as new...

Hi Maldowl. The market only wakes up to CDY events such as new licence signings. Otherwise we remain a completely unnoticed blip on investor radar screens. At least we get enough coverage to be on the proverbial screen. I am hoping that some additional lung cancer dx licences my follow over the next year however licences don't just arrive instantly on news of the Quest licence no longer being exclusive.

As advised, Quest will have their discussion with the FDA on the PLOS /lungdx study results towards the end of the year. In a sense, no news is good news because any bad news would likely have been conveyed before now IMHO. When the results of that meeting are tabled Mr Market will take notice.

cheers